OPPENHEIMER ASSET MANAGEMENT INC.

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1269119 NEW YORK, NY

Position in MDGL

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$663,670

-$30,974 QoQ

Shares Held

1,236

-6.9% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#227

of 411 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

OPPENHEIMER ASSET MANAGEMENT INC. holds $60,234,083 across 32 Biotechnology names. MDGL ranks #17 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GMAB	Genmab A/S	447,426	$12,290,791
2	ONC	BeOne Medicines Ltd.	35,781	$10,196,511
3	VRTX	Vertex Pharmaceuticals Inc / Ma	17,931	$8,906,863
4	ALNY	Alnylam Pharmaceuticals, Inc.	19,608	$5,902,596
5	TECH	BIO-TECHNE Corp	39,080	$2,760,999
6	HALO	Halozyme Therapeutics, Inc.	29,098	$2,277,499
7	JAZZ	Jazz Pharmaceuticals plc	8,356	$2,013,545
8	INSM	INSMED Inc	16,061	$1,712,423

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$663,670	1,236	-6.9%	Shares	Other	2026-08-03
2026-03-31	$694,644	1,327	+1.1%	Shares	Other	2026-04-24
2025-12-31	$764,612	1,313	+18.7%	Shares	Other	2026-02-02
2025-09-30	$507,277	1,106	-1.2%	Shares	Other	2025-11-06
2025-06-30	$338,956	1,120	-6.9%	Shares	Other	2025-07-31
2025-03-31	$398,469	1,203	+6.3%	Shares	Other	2025-04-23
2024-12-31	$349,301	1,132	-24.9%	Shares	Other	2025-02-05
2024-09-30	$319,815	1,507	+2.1%	Shares	Other	2024-11-05
2024-06-30	$413,515	1,476	—	Shares	Other	2024-08-08
No filing history on record for this holder in this stock.